Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL754932 | 0.87 | CYP2A6 (0.46) | NQO2ALDH1A1TDP1MAOBMAOA | |
| SCHEMBL15223489 | 0.84 | CYP2A6 (0.48) | NQO2ALDH1A1TDP1MAOBMAOA | |
| SCHEMBL12403114 | 0.82 | TSHR (0.37) | NQO2ALDH1A1TSHRMAPK1 | |
| SCHEMBL12403076 | 0.81 | MAOB (0.35) | NQO2ALDH1A1TDP1MAOBMAOA | |
| SCHEMBL12403145 | 0.80 | CYP2A6 (0.44) | NQO2ALDH1A1TDP1MAOBMAOA | |
| SCHEMBL754915 | 0.80 | CYP3A4 (0.32) | ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL12403144 | 0.79 | CYP2A6 (0.37) | ALDH1A1TDP1MAOBMAOAHSD17B10 | |
| SCHEMBL2347027 | 0.79 | TSHR (0.38) | NQO2ALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL12403143 | 0.78 | MAOB (0.46) | ALDH1A1TDP1MAOBMAOAHSD17B10 | |
| SCHEMBL752710 | 0.78 | TERT (0.33) | TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7985885-B2 | Terphenylene derivative, tetrahaloterphenyl derivative, and processes for producing both | TOSOH CORPORATION (JP) | 2011-07-26 | — | — | US | disclosed |
| US-20090023957-A1 | TERPHENYLENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING BOTH | TOSOH CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023957-A1 | TERPHENYLENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING BOTH | TERT, TLN1, TTI1 | NQO2 3638/4885ALDH1A1 954/4885TDP1 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.